Current conditions and developments for radical therapies of small hepatocellular carcinoma

Abstract

Abstract: Hepatocellular carcinoma (HCC) is one of the most frequently occurring types of malignancy.With the improvement of cancer surveillance and the development of advanced imaging technology,the early diagnosis of primary small HCC(diameter≤3cm ) have significantly increased.In the context of the small HCC,surgical resection(SR),ablation,and liver transplantation(LT)remain the cornerstone of therapy.We will review the current status and progress of surgical resection, ablation and liver transplantation.

Key words: Small hepatocellular carcinoma, Surgery resection, Ablation, Liver transplant

Shang Fuchao, Wang Menglong. Current conditions and developments for radical therapies of small hepatocellular carcinoma[J]. Electronic Journal of Liver Tumor, 2020, 7(4): 9-12.

References

[1] BRAY F, FERLAY J, SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424 .
[2] GALLE P R, FORNER A, LLOVET J M, et al.EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1):182-236.
[3] MARRERO JA, KULIK LM, SIRLIN CB, et al.Diagnosis, Staging, and Management of Hepatocellular Carcinoma:2018 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2):723-750.
[4] VILLANUEVA A.Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380(15):1450-1462.
[5] ROAYAIE S, JIBARA G, TABRIZIAN P, et al.The role of hepatic resection in the treatment of hepatocellular cancer[J]. Hepatology, 2015, 62(2):440-451.
[6] POON RT, NG IO, FAN ST,et al.Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma:a study of a prospective cohort[J]. J Clin Oncol, 2001, 19(12):3037-3044.
[7] CHA SW, SOHN JH, KIM SH, et al.Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2020, 35(4):648-653.
[8] JU M, YOPP A C.The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma:Associated with Improved Outcomes or Lack of Supportive Evidence?[J]. Cancers, 2019, 11(10):1441.
[9] JIAO S, LI G, ZHANG D, et al.Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis[J]. Int J Surg, 2020,80:243-255.
[10] BUELL JF, CHERQUI D, GELLER DA, et al.World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery:The Louisville Statement[J]. Ann Surg. 2009, 250(5):825-830.
[11] WITOWSK J, RUBINKIEWICZ M, MIZERA M, et al.Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients[J]. Surg Endosc, 2019, 33(5):1491-1507.
[12] HALAZUN KJ, NAJJAR M, ABDELMESSIH RM, et al.Recurrence after Liver Transplantation for hepatocellular carcinoma:A New MORAL to the Story[J]. Ann Surg, 2017, 265(3):557-564.
[13] BHANGUI P, ALLARD MA, VIBBERT E, et al.Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma:Do Both Strategies Yield Similar Outcomes?[J]. Ann Surg, 2016, 264(1):155-163.
[14] YADAV DK, CHEN W, BAI X, et al.Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma[J]. Ann Transplant, 2018, 23:524-545.
[15] INCHINGOLO R, POSA A, MARIAPPAN M, et al.Locoregional treatments for hepatocellular carcinoma:Current evidence and future directions[J]. World J Gastroenterol, 2019, 25(32):4614-4628.
[16] KANG TW, KIM JM, RHIM H, et al.Small Hepatocellular Carcinoma:Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes[J]. Radiology, 2015, 275(3):908-919.
[17] XU Q, KOBAYASHI S, Ye X, et al.Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma:a meta-analysis of 16,103 patients[J]. Sci Rep, 2014, 4:7252.
[18] NAULT C, SUTTER O, NAHON P, et al.Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations[J]. J Hepatol, 2018, 68(4):783-797.
[19] VOGL TJ, FARSHID P, NAQUIB NN, et al.Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation[J]. Abdom Imaging, 2015, 40(6):1829-1837.
[20] FACCIORUSSO A, DI MASO M, MUSCATIELLO N.et al.Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma:A systematic review and meta-analysis[J]. Int J Hyperthermia, 2016, 32(3):339-344.
[21] CHONG CCN, LEE KF, CHEUNG SYS, et al.Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial)[J]. HPB (Oxford), 2020, 22(8):1121-1127.
[22] Du S, Yang JZ, Chen J, et al.Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma:A multiple centers retrospective cohort study with propensity score matching[J]. PLoS One, 2020, 15(1):e0227242.
[23] ZHANG M, MA H, ZHANG J, et al.Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma:a meta-analysis[J]. Onco Targets Ther, 2017, 10:4829-4839.
[24] 24.DAHER S, MASSARWA M, BENSON AA, et al. Current and Future Treatment of Hepatocellular Carcinoma:An Updated Comprehensive Review[J]. J Clin Transl Hepatol, 2018, 6(1):69-78.
[25] POMPILI M, DE MATTHAEIS N, SAVIANO A, et al.Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?[J]. Anticancer Res, 2015, 35(1):325-332.
[26] LUO W, ZHANG Y, HE G, et al.Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas:a systematic review and meta-analysis[J]. World J Surg Oncol, 2017, 15(1):126.
[27] DI COSTANZO GG, FRANCICA G, PACELLA CM.Laser ablation for small hepatocellular carcinoma:State of the art and future perspectives[J]. World J Hepatol, 2014, 6(10):704-715.
[28] SEROR O.Ablative therapies:Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?[J]. Diagn Interv Imaging, 2015, 96(6):617-624.